@article{c7de1d7a5155479bbbf88f8b396113bc,
title = "Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine",
abstract = "No Abtsract",
keywords = "Adult, Aged, Antimetabolites, Antineoplastic, Azacitidine, DNA Methylation, DNA-Binding Proteins, Female, Humans, Male, Middle Aged, Mutation, Myelodysplastic Syndromes, Prognosis, Proto-Oncogene Proteins, Proto-Oncogene Proteins c-bcl-2, Retrospective Studies, Risk Factors, Survival Rate, Adult, Aged, Antimetabolites, Antineoplastic, Azacitidine, DNA Methylation, DNA-Binding Proteins, Female, Humans, Male, Middle Aged, Mutation, Myelodysplastic Syndromes, Prognosis, Proto-Oncogene Proteins, Proto-Oncogene Proteins c-bcl-2, Retrospective Studies, Risk Factors, Survival Rate",
author = "Voso, {Maria Teresa} and Emiliano Fabiani and A Piciocchi and C Matteucci and L Brandimarte and C Finelli and E Pogliani and E Angelucci and G Fioritoni and P Musto and Mariangela Greco and Marianna Criscuolo and Luana Fianchi and M Vignetti and V Santini and Stefan Hohaus and C Mecucci and Giuseppe Leone",
year = "2011",
doi = "10.1038/leu.2011.170",
language = "English",
volume = "25",
pages = "1910--1913",
journal = "Leukemia",
issn = "0887-6924",
publisher = "Springer Nature",
}